Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.

Also called NCT02802306

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 201 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02802306
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Belgium, Germany, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02802306. Allocation not applicable; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2019-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
Acronym
TOBA III
Condition
Peripheral Arterial Disease
Intervention (Device)
Tack Endovascular System
Lead sponsor
Philips Clinical & Medical Affairs Global (class: industry)

Record details

Record id
cardio:ct-nct02802306
Content hash
bd3c2e12af7d9aef5daa55854427a97748cdeaa51ca3f69f8c9f09206c2f7dd3